Pressure Biosciences Stock Cash Per Share
Pressure Biosciences fundamentals help investors to digest information that contributes to Pressure Biosciences' financial success or failures. It also enables traders to predict the movement of Pressure OTC Stock. The fundamental analysis module provides a way to measure Pressure Biosciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Pressure Biosciences otc stock.
Pressure |
Pressure Biosciences OTC Stock Cash Per Share Analysis
Pressure Biosciences' Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.
Current Pressure Biosciences Cash Per Share | 0.01 X |
Most of Pressure Biosciences' fundamental indicators, such as Cash Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Pressure Biosciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Companies with high Cash per Share ratio will be considered as an attractive investment by most investors. In most industries if you can single out an equity instrument trading below its cash per share value, you have a bargain and should consider buying it. Finding the stocks traded below their cash value, therefore, can be a good starting point for investors using strategies based on fundamentals.
CompetitionIn accordance with the recently published financial statements, Pressure Biosciences has a Cash Per Share of 0.01 times. This is 99.77% lower than that of the Life Sciences Tools & Services sector and 99.62% lower than that of the Health Care industry. The cash per share for all United States stocks is 99.8% higher than that of the company.
Pressure Cash Per Share Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Pressure Biosciences' direct or indirect competition against its Cash Per Share to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Pressure Biosciences could also be used in its relative valuation, which is a method of valuing Pressure Biosciences by comparing valuation metrics of similar companies.Pressure Biosciences is currently under evaluation in cash per share category among its peers.
Pressure Fundamentals
| Return On Asset | -0.93 | ||||
| Operating Margin | (3.18) % | ||||
| Current Valuation | 33.23 M | ||||
| Shares Outstanding | 11.07 M | ||||
| Shares Owned By Insiders | 1.27 % | ||||
| Shares Owned By Institutions | 0.05 % | ||||
| Number Of Shares Shorted | 6.34 K | ||||
| Price To Earning | (1.05) X | ||||
| Price To Sales | 9.95 X | ||||
| Revenue | 2 M | ||||
| Gross Profit | 1.06 M | ||||
| EBITDA | (5.59 M) | ||||
| Net Income | (20.15 M) | ||||
| Cash And Equivalents | 121.57 K | ||||
| Cash Per Share | 0.01 X | ||||
| Total Debt | 150 K | ||||
| Debt To Equity | 2.04 % | ||||
| Current Ratio | 0.07 X | ||||
| Book Value Per Share | (2.44) X | ||||
| Cash Flow From Operations | (4.87 M) | ||||
| Short Ratio | 3.00 X | ||||
| Earnings Per Share | (2.59) X | ||||
| Target Price | 1.57 | ||||
| Number Of Employees | 12 | ||||
| Beta | 0.73 | ||||
| Market Capitalization | 23.22 M | ||||
| Total Asset | 2.83 M | ||||
| Retained Earnings | (81.02 M) | ||||
| Working Capital | 9.2 M | ||||
| Current Asset | 13.07 M | ||||
| Current Liabilities | 3.88 M | ||||
| Z Score | 53.5 | ||||
| Net Asset | 2.83 M |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Other Consideration for investing in Pressure OTC Stock
If you are still planning to invest in Pressure Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Pressure Biosciences' history and understand the potential risks before investing.
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |